Insomnia Market Size to Exceed US$ 6.1 Billion by 2028, with a Robust CAGR of 3% | Exclusive Report By IMARC Group

IMARC Group, a leading market research company, has recently releases report titled "Insomnia Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028." The study provides a detailed analysis of the industry, including the global insomnia market growth, trends, size, share and forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How Big Is the Insomnia Market?

The global insomnia market size reached US$ 5.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.1 Billion by 2028, exhibiting a growth rate (CAGR) of 3% during 2023-2028.

Request a sample of report: https://www.imarcgroup.com/insomnia-market/requestsample

What is Insomnia?

Insomnia is a sleep disorder characterized by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep, which can result in daytime fatigue and impaired functioning. It can be caused by worries and concerns that can keep the mind active, making it challenging to relax and fall asleep. It is affected by irregular sleep schedules, excessive caffeine or alcohol intake, and using electronic devices before bedtime. It is also responsible for sleep disturbances due to chronic pain, allergies, asthma, and conditions like restless leg syndrome. Moreover, irregular work hours disrupt the natural circadian rhythm of the body, making it difficult to establish a regular sleep pattern.

Insomnia Market Trends and Drivers:

Presently, insomnia is a pervasive issue affecting individuals across the globe. This high prevalence is compelling healthcare systems to prioritize insomnia treatment as a means of improving public health. Besides this, governing agencies and employers are recognizing the importance of addressing the issue of insomnia to enhance overall well-being and work efficiency. In addition, the increasing awareness about the close relationship between insomnia and mental health conditions, such as depression and anxiety, is highlighting the need for early diagnosis and treatment. This is spurring initiatives to provide accessible mental health support globally. Apart from this, ongoing scientific research is yielding a better understanding of insomnia's underlying causes and effective treatment options. This knowledge is encouraging healthcare providers to adopt evidence-based approaches. Moreover, the growing number of telehealth and digital health platforms is making insomnia treatment more accessible to individuals in remote or underserved areas. It enables the delivery of cognitive-behavioral therapy for insomnia (CBT-I) and other interventions online. In line with this, as lifestyle is becoming increasingly hectic and intertwined with global business and travel, managing insomnia is vital for individuals to adapt to changing time zones and work demands. Furthermore, the demographic shift is leading to the rising need for effective treatments to improve the sleep quality of older adults.

Ask Analyst for 10% free customized report: https://www.imarcgroup.com/request?type=report&id=6148&flag=C

What Is Included In Market Segmentation?

The report has been segmented the market into following categories:

Breakup by Therapy Type:
• Non-Pharmacological Therapy
o Hypnotherapy
o Cognitive Behavioral Therapy
o Medical Devices
o Others
• Pharmacological Therapy
o Prescription Sleep Aids
o Over-The-Counter Sleep Aids

Breakup by Drug Class:
• Antidepressants
• Melatonin Antagonist
• Benzodiazepines
• Nonbenzodiazepines
• Orexin Antagonist
• Others

Breakup by Distribution Channel:
• Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies

Breakup by Region:
• North America
o United States
o Canada
• Asia-Pacific
o China
o Japan
o India
o South Korea
o Australia
o Indonesia
o Others
• Europe
o Germany
o France
o United Kingdom
o Italy
o Spain
o Russia
o Others
• Latin America
o Brazil
o Mexico
o Others
• Middle East and Africa

Key highlights of the Report:
• Market Performance (2018-2023)
• Market Outlook (2023-2028)
• COVID-19 Impact on the Market
• Porter's Five Forces Analysis
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

TOC for the Report:
• Preface
• Scope and Methodology
• Executive Summary
• Introduction
• SWOT Analysis
• Value Chain Analysis
• Price Analysis
• Competitive Landscape

Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.